PMC:7195088 / 21737-22029
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 676 | 50-58 | Species | denotes | patients | Tax:9606 |
| 677 | 282-290 | Species | denotes | patients | Tax:9606 |
| 801 | 24-34 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 802 | 206-216 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 803 | 221-239 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 804 | 244-254 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 805 | 260-278 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 942 | 64-72 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T13 | 173-178 | Body_part | denotes | scale | http://purl.obolibrary.org/obo/UBERON_0002542 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T106 | 64-72 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T106 | 155-158 | http://purl.obolibrary.org/obo/CLO_0050154 | denotes | a 8 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T242 | 24-34 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T243 | 206-216 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T244 | 221-239 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T245 | 244-254 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T246 | 260-278 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T157 | 8-73 | Sentence | denotes | • Comparison of remdesivir vs. placebo in patients with COVID-19. |
| T158 | 74-117 | Sentence | denotes | Double-blind RCT (NCT04280705, recruiting). |
| T159 | 118-189 | Sentence | denotes | Primary endpoint: severity rating on a 8-point ordinal scale at day 15. |